67Ga scintigraphy as an index of disease activity in pulmonary sarcoidosis

1981 ◽  
Vol 6 (5) ◽  
pp. 205-212 ◽  
Author(s):  
Chr. Alberts ◽  
J. B. van der Schoot ◽  
A. S. Groen
Radiology ◽  
1994 ◽  
Vol 191 (3) ◽  
pp. 675-680 ◽  
Author(s):  
M Remy-Jardin ◽  
F Giraud ◽  
J Remy ◽  
L Wattinne ◽  
B Wallaert ◽  
...  

2005 ◽  
Vol 99 (4) ◽  
pp. 396-402 ◽  
Author(s):  
Julia S. Johansen ◽  
Nils Milman ◽  
Michael Hansen ◽  
Charly Garbarsch ◽  
Paul A. Price ◽  
...  

1983 ◽  
Vol 8 (8) ◽  
pp. 351-353 ◽  
Author(s):  
J. G. van Unnik ◽  
E. A. van Roven ◽  
C. Alberts ◽  
J. B. van der Schoot

CHEST Journal ◽  
1982 ◽  
Vol 82 (1) ◽  
pp. 7-9 ◽  
Author(s):  
Richard S. Ackart ◽  
Thomas L. Munzel ◽  
James J. Rodriguez ◽  
Charles J. Donlan ◽  
Ronald J. Klayton ◽  
...  

Thorax ◽  
2016 ◽  
Vol 71 (12) ◽  
pp. 1161-1163 ◽  
Author(s):  
Rachel Benamore ◽  
Yvonne R Kendrick ◽  
Emmanouela Repapi ◽  
Emma Helm ◽  
Suzanne L Cole ◽  
...  

2016 ◽  
Vol 47 (4) ◽  
pp. 1198-1207 ◽  
Author(s):  
Roeland Vis ◽  
Gaurav Malviya ◽  
Alberto Signore ◽  
Jan C. Grutters ◽  
Bob Meek ◽  
...  

Infliximab, a monoclonal antibody directed against tumour necrosis factor (TNF)-α, is used in the treatment of refractory sarcoidosis. However, the clinical response is variable and a tool to select responders beforehand is highly desirable. In this study we evaluated scintigraphy with technetium-99m (99mTc)-labelled infliximab for the imaging of disease activity in patients with pulmonary sarcoidosis.10 patients were studied using single photon emission computed tomography/computed tomography (CT) 6 h and 20 h after intravenous administration of 370 MBq of 99mTc-infliximab. Correlation analysis was performed between tissue accumulation of 99mTc-infliximab and laboratory parameters (including soluble interleukin-2 receptor and angiotensin-converting enzyme), lung function parameters (including forced expiratory volume in 1 s and the diffusing capacity of the lung for carbon monoxide) and 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT.Analysis showed selective and variable accumulation of 99mTc-infliximab in the target tissue. Accumulation correlated positively with all four laboratory parameters and negatively with all four lung function parameters, yielding better correlations than serum TNF-α levels or 18F-FDG PET/CT.99mTc-infliximab accumulation reflects the in situ TNF-α expression in an individual patient and therefore provides valuable information on the presence of the biological target for anti-TNF-α therapy.


Thorax ◽  
1984 ◽  
Vol 39 (2) ◽  
pp. 143-149 ◽  
Author(s):  
G A Rossi ◽  
O Sacco ◽  
E Cosulich ◽  
G Damiani ◽  
G Corte ◽  
...  

Thorax ◽  
2016 ◽  
Vol 71 (Suppl 3) ◽  
pp. A103.2-A103
Author(s):  
YK Kendrick ◽  
E Repapi ◽  
E Helm ◽  
SL Cole ◽  
R Hoyles ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document